Glenmark Pharma Share Price Surges 10% on $700M AbbVie Licensing Deal
In a major development shaking up the Indian stock market, the Glenmark Pharma share price soared 10% today after the company announced a global licensing deal worth $700 million with pharmaceutical giant AbbVie. The partnership, focused on a cutting-edge oncology molecule developed by Glenmark’s innovation arm, signals a strategic leap into the global cancer treatment … Read more